Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-21 02:00 |
Xlife Sciences mit signifikanten Fortschritten im 1. Halbjahr 2023
|
German | HTML • 15.6 KB | ||
| 2023-08-17 09:45 |
Collaboration of Xlife Sciences and the Department of Health Abu Dhabi to driv…
|
English | HTML • 12.6 KB | ||
| 2023-08-17 02:00 |
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to dri…
|
English | HTML • 10.7 KB | ||
| 2023-08-17 02:00 |
Kooperation der Xlife Sciences AG und dem Department of Health - Abu Dhabi zur …
|
German | HTML • 13.8 KB | ||
| 2023-06-20 17:00 |
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved…
|
English | HTML • 10.0 KB | ||
| 2023-06-20 02:00 |
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved…
|
English | HTML • 8.2 KB | ||
| 2023-06-20 02:00 |
Medienmitteilung
Zürich, 20. Juni 2023
Xlife Sciences: Aktionärinnen und …
|
German | HTML • 8.8 KB | ||
| 2023-05-26 07:00 |
Xlife Sciences publishes agenda for Annual General Meeting 2023
|
English | HTML • 9.7 KB | ||
| 2023-05-26 02:00 |
Xlife Sciences publishes agenda for Annual General Meeting 2023
|
English | HTML • 8.3 KB | ||
| 2023-05-26 02:00 |
Xlife Sciences veröffentlicht Traktanden der Generalversammlung 2023
|
German | HTML • 10.6 KB | ||
| 2023-04-27 07:00 |
Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfol…
|
English | HTML • 12.0 KB | ||
| 2023-04-27 02:00 |
Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfol…
|
English | HTML • 10.1 KB | ||
| 2023-04-27 02:00 |
Xlife Sciences: Valuation Report 2022 bestätigt und unterstreicht langfristiges…
|
German | HTML • 12.2 KB | ||
| 2023-04-20 07:00 |
Xlife Sciences publishes 2022 results and 2023 outlook
|
English | HTML • 23.0 KB | ||
| 2023-04-20 02:00 |
Xlife Sciences publishes 2022 results and 2023 outlook
|
English | HTML • 21.3 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
